SCSiraprapa Chansatidkosol

Siraprapa Chansatidkosol

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Siraprapa Chansatidkosol has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Injectability and mechanical properties of borneol-based solvent removal-induced in situ matrix for periodontal pocket delivery

    by Nutdanai Lertsuphotvanit, Siraprapa Chansatidkosol, Tiraniti Chuenbarn, Thawatchai Phaechamud

    Solvent removal-induced in situ matrices (ISMs) have garnered attention for periodontitis treatment because of their capability to localize antibiotic drug release within the periodontal pocket over an extended duration, effectively targeting and eliminating infecting microbes. In this study, various concentrations of borneol—10%–70%—were used as a matrix agent in ISMs, with a 40% w/w borneol-based ISM selected to load 1% vancomycin HCl. The injectability and mechanical properties of drug-free and vancomycin HCl-loaded borneol ISMs were evaluated with a texture analyzer. Both maximum injection force and energy increased proportionally with borneol concentrations and slightly further with vancomycin HCl. Nevertheless, the injection energy required for borneol-loaded ISMs at 10%–50% was low, from 12.22–25.00 mJ. Consequently, these formulations were considered appropriate and feasible as injectable drug delivery systems, providing ease of administration while promoting patient comfort and compliance. Additionally, a more compact borneol matrix was formed after complete solvent removal; it exhibited plastic deformation, enabling close adaptation to the periodontal pocket geometry.

  • Open Access

    Water Tolerance and Matrix Morphology of Aqueous-induced Borneol-based In Situ Matrix Formation for Periodontal Pocket Delivery

    by Siraprapa Chansatidkosol, Thawatchai Phaechamud, Nichthima Warinthip, Nutdanai Lertsuphotvanit

    In situ forming matrix systems (ISMs) have gained increasing attention for localized drug delivery, particularly for periodontal pocket treatment through injection. Crevicular fluid exposure can induce a phase transformation of the ISM from a solution into a matrix. Organic solvents, including ethanol, N-methyl pyrrolidone (NMP), dimethyl sulfoxide (DMSO), and 2-pyrrolidone, are typically used in ISM formulations due to their water miscibility and biocompatibility. In this study, 40% borneol solutions in these solvents were used as the matrix former. The water tolerance, defined as the minimum amount of water needed to induce phase inversion from a solution into a matrix, was investigated employing an aqueous titration technique. The water tolerance levels for borneol were 39.65%, 14.77%, 7.40%, and 6.71% v/v in ethanol, NMP, DMSO, and 2-pyrrolidone, respectively. Borneol in DMSO demonstrated low water tolerance and low viscosity (5.61 ± 0.12 cPs), which facilitates rapid matrix formation and ease of administration into the periodontal pocket. Thus, DMSO was considered a suitable solvent for borneol-based ISM. Further, the morphology of the borneol crystal matrix was evaluated under an inverted stereomicroscope at various borneol concentrations (10%–60%). Formulations with lower borneol concentrations required more time to crystallize than those with higher concentrations. The resulting crystal matrix entrapped the drug, thereby retarding its release. The choice of solvent and borneol concentration significantly affected the matrix formation rate and morphology. Therefore, the appropriate selection of solvent and borneol concentration is crucial for developing an aqueous-induced borneol-based ISM for periodontitis treatment.

  • Open Access

    Cellulose Acetate Butyrate-Based In Situ Gel Comprising Doxycycline Hyclate and Metronidazole

    by Ei Mon Khaing, Nutdanai Lertsuphotvanit, Warakon Thammasut, Catleya Rojviriya, Siraprapa Chansatidkosol, Supanut Phattarateera, Wiwat Pichayakorn, Thawatchai Phaechamud

    Cellulose acetate butyrate is a biodegradable cellulose ester bioplastic produced from plentiful natural plant-based resources. Solvent-exchange-induced in situ gels are particularly promising for periodontitis therapy, as this dosage form allows for the direct delivery of high concentrations of antimicrobial agents to the localized periodontal pocket. This study developed an in situ gel for periodontitis treatment, incorporating a combination of metronidazole and doxycycline hyclate, with cellulose acetate butyrate serving as the matrix-forming agent. Consequently, assessments were conducted on the physicochemical properties, gel formation, drug permeation, drug release, morphological topography, and antimicrobial activities of the formulation. The formulation demonstrated an increased slope characteristic of Newtonian flow at higher bioplastic concentrations. The adequate polymer concentration facilitated swift phase inversion, resulting in robust, solid-like matrices. The mechanical characteristics of the transformed in situ gel typically exhibit an upward trend as the polymer concentration increased. The utilization of sodium fluorescein and Nile red as fluorescent probes effectively tracked the interfacial solvent–aqueous movement during the phase inversion of in situ gels, confirming that the cellulose acetate butyrate matrix delayed the solvent exchange process. The initial burst release of metronidazole and doxycycline hyclate was minimized, achieving a sustained release profile over 7 days in in situ gels containing 25% and 40% cellulose acetate butyrate, primarily governed by a diffusion-controlled release mechanism. Metronidazole showed higher permeation through the porcine buccal membrane, while doxycycline hyclate exhibited greater tissue accumulation, both influenced by polymer concentration. The more highly concentrated polymeric in situ gel formed a uniformly porous structure. Metronidazole and doxycycline hyclate-loaded in situ gels showed synergistic antibacterial effects against S. aureus and P. gingivalis. Over time, the more highly concentrated polymeric in situ gel showed superior retention of antibacterial efficacy due to its denser cellulose acetate butyrate matrix, which modulated drug release and enhanced synergistic effects, making it a promising injectable treatment for periodontitis, particularly against P. gingivalis.